EDAP ABLATHERM INTEGRATED IMAGING

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-02-17 for EDAP ABLATHERM INTEGRATED IMAGING manufactured by Edap Tms France Sa.

Event Text Entries

[71247169] A (b)(6) man underwent prostate hemiablation with edap ablatherm for gleason 7 prostate cancer in (b)(6) 2016. Patient experienced 3 episodes of urinary retention. Had to be hospitalized on two occasions. First time for clot evaluation from hematuria.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5068716
MDR Report Key6442255
Date Received2017-02-17
Date of Report2017-02-06
Date of Event2016-12-15
Date Added to Maude2017-03-29
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameEDAP ABLATHERM INTEGRATED IMAGING
Generic NameEDAP ABLATHERM INTEGRATED IMAGING
Product CodePLP
Date Received2017-02-17
OperatorNO INFORMATION
Device Availability*
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerEDAP TMS FRANCE SA


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2017-02-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.